Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: ACCESS Pharmaceuticals
Woman
Between 18 years
and 99 years
ACCESS Pharmaceuticals
Update Il y a 4 ans
APC10E604 : Essai de phase 2 évaluant l’efficacité de l’association du ProLindac™ et du paclitaxel, en traitement de seconde ligne, chez des patientes ayant un cancer de l’ovaire avancé. [essai clos aux inclusions]
L’objectif de cet essai est d’évaluer l’efficacité de l’association du ProLindac™ et du paclitaxel, en traitement de seconde ligne chez des patientes ayant un cancer de l’ovaire avancé. Les patientes...
Country
France
organs
Ovaire
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Woman Max 99 years
ACCESS Pharmaceuticals, Inc
Update Il y a 4 ans
A Phase II Trial of ProLindac™ and Paclitaxel Combination as Second Line-Treatment in Platinum Pretreated Patients with Advanced Ovarian Cancer
To evaluate the efficacy of ProLindac combined with paclitaxel in patients with advanced epithelial ovarian cancer, previously treated with cisplatin or carboplatin, who are potentially platinum-sensi...
Country
None
organs
None
Specialty
None
Closed trial
More information